The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Shishioh Ikejima, Nobue ^a   Ogawa, Tokiko ^a   Yamaguti, Kouzi ^a   Watanabe, Yasuyoshi ^a,b   Kuratsune, Hirohiko ^a,c,d   Kiyama, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c KANSAI UNIVERSITY OF WELFARE SCIENCES   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; HYDROCORTISONE; PRASTERONE SULFATE; BIOLOGICAL MARKER;

ADULT; ALPHA INTERMEDIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE DURATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ANALYSIS OF VARIANCE; BLOOD; BODY MASS; CASE CONTROL STUDY; PHOTOPERIODICITY; STATISTICAL ANALYSIS; TIME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALPHA-MSH; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; DEHYDROEPIANDROSTERONE SULFATE; FASTING; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; MALE; PHOTOPERIOD; TIME FACTORS;

EID: 77955789591     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-73     Document Type: Article

References (26)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994, 121:953-9.
2. Kuratsune H, Yamaguti K, Lindh G, Evengård B, Hagberg G, Matsumura K, Iwase M, Onoe H, Takahashi M, Machii T, Kanakura Y, Kitani T, Långström B, Watanabe Y. Brain regions involved in fatigue sensation: Reduced acetylcarnitine uptake into the brain. Neuroimage 2002, 17:1256-65. 10.1006/nimg.2002.1260, 12414265.
3. Watanabe Y, Kuratsune H. Brain Science on Chronic Fatigue. Jpn Med A J 2006, 49:19-28.
4. Jason LA, Torres-Harding SR, Carrico AW, Taylor RR. Symptom occurrence in persons with chronic fatigue syndrome. Biol Psychol 2002, 59:15-27. 10.1016/S0301-0511(01)00120-X, 11790441.
5. Narita M, Nishigami N, Narita N, Yamaguti K, Okado N, Watanabe Y, Kuratsune H. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 2003, 311:264-6. 10.1016/j.bbrc.2003.09.207, 14592408.
6. Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med 2009, 7:96. 10.1186/1479-5876-7-96, 2779802, 19909538.
7. Tanaka M, Nakamura F, Mizokawa S, Matsumura A, Nozaki S, Watanabe Y. Establishment and assessment of a rat model of fatigue. Neurosci Lett 2003, 352:159-62. 10.1016/j.neulet.2003.08.051, 14625009.
8. Ogawa T, Kiryu-Seo S, Tanaka M, Konishi H, Iwata N, Saido T, Watanabe Y, Kiyama H. Altered expression of neprilysin family members in the pituitary gland of sleep-disturbed rats, an animal model of severe fatigue. J Neurochem 2005, 95:1156-66. 10.1111/j.1471-4159.2005.03436.x, 16271049.
9. Ogawa T, Shishioh-Ikejima N, Konishi H, Makino T, Sei H, Kiryu-Seo S, Tanaka M, Watanabe Y, Kiyama H. Chronic stress elicits prolonged activation of alpha-MSH secretion and subsequent degeneration of melanotroph. J Neurochem 2009, 109:1389-99. 10.1111/j.1471-4159.2009.06057.x, 19476550.
10. Airaghi L, Capra R, Pravettoni G, Maggiolo F, Suter F, Lipton JM, Catania A. Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. J Lab Clin Med 1999, 133:309-15. 10.1016/S0022-2143(99)90087-2, 10072263.
11. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003, 24:236-52.
12. Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, Kitani T. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1998, 1:143-6.
13. Späth M, Welzel D, Färber L. Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists--preliminary results. Scand J Rheumatol Suppl 2000, 113:72-7. 10.1080/030097400446698, 11028837.
14. Donahoo WT, Hernandez TL, Costa JL, Jensen DR, Morris AM, Brennan MB, Hochgeschwender U, Eckel RH. Plasma alpha-melanocyte-stimulating hormone: sex differences and correlations with obesity. Metabolism 2009, 58:16-21. 10.1016/j.metabol.2008.07.028, 19059526.
15. Hoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) 2004, 61:31-9. 10.1111/j.1365-2265.2004.02056.x, 15212642.
16. Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism 2002, 51(6 Suppl 1):5-10. 10.1053/meta.2002.33184, 12040534.
17. Katsuki A, Sumida Y, Murashima S, Furuta M, Araki-Sasaki R, Tsuchihashi K, Hori Y, Yano Y, Adachi Y. Elevated plasma levels of alpha-melanocyte stimulating hormone (alpha-MSH) are correlated with insulin resistance in obese men. Int J Obes Relat Metab Disord 2000, 24:1260-4. 10.1038/sj.ijo.0801400, 11093286.
18. Pichler R, Crespillo C, Maschek W, Esteva I, Soriguer F, Sfetsos K, Auböck J. Plasma levels of alpha-melanotropin and ACTH-like immunoreactivities do not vary by season or skin type in women from southern and central Europe. Neuropeptides 2004, 38:325-30. 10.1016/j.npep.2004.07.003, 15464199.
19. Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T. Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med 2006, 45:429-34. 10.2169/internalmedicine.45.1546, 16679696.
20. Sharpe M, Clements A, Hawton K, Young AH, Sargent P, Cowen PJ. Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 1996, 41:71-6. 10.1016/0165-0327(96)00075-4, 8938208.
21. Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, Gattinoni L. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med 2000, 28:1403-7. 10.1097/00003246-200005000-00024, 10834686.
22. Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 1997, 18:140-5. 10.1016/S0167-5699(97)01009-8, 9078687.
23. Robertson B, Dostal K, Daynes RA. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol 1988, 140:4300-7.
24. Yoon SW, Goh SH, Chun JS, Cho EW, Lee MK, Kim KL, Kim JJ, Kim CJ, Poo H. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem 2003, 278:32914-20. 10.1074/jbc.M302444200, 12816950.
25. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 23:585-9.
26. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010, 5:e8519. 10.1371/journal.pone.0008519, 2795199, 20066031.